
117.06 Delayed Data As of Jan 22 | ![]() Today’s Change | 72.14 Today|||52-Week Range 136.26 | +22.13% Year-to-Date |
The 22 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 121.50, with a high estimate of 145.00 and a low estimate of 90.00. The median estimate represents a +3.79% increase from the last price of 117.06.
The current consensus among 25 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.